Introducing our latest innovative product in medical diagnostics - the Direct Immunoassay. This cutting-edge technology allows for the direct detection and measurement of specific substances in the body, such as hormones, drugs, and cancer markers, without the need for additional sample preparation steps. Our Direct Immunoassay kit is designed to streamline the testing process, saving time and reducing the potential for errors. By eliminating the need for sample pretreatment, our immunoassay delivers faster results, enabling healthcare professionals to make rapid and informed decisions for their patients. With its high sensitivity and specificity, our Direct Immunoassay offers accurate and reliable results, making it an invaluable tool for clinical laboratories, hospitals, and research facilities. The kit is easy to use and can be seamlessly integrated into existing laboratory workflows. In addition to its efficiency and accuracy, our Direct Immunoassay is also designed with patient comfort in mind. It requires minimal sample volume, reducing the discomfort for patients undergoing testing. We are committed to advancing the field of medical diagnostics, and our Direct Immunoassay represents the latest advancement in this mission. With its ability to provide fast, accurate, and convenient testing, we believe it will have a significant impact on improving patient care and outcomes. Join us in revolutionizing medical diagnostics with our Direct Immunoassay.

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise in China specializing in the development and production of in vitro diagnostic reagents, has recently introduced a new Rtk Antigen Self T

Beijing, China - In a groundbreaking development, researchers at Beijing Beier Bioengineering Co., Ltd. have announced a major breakthrough in the fight against Treponema Pallidum, the bacterium that